OPEC+ nations are maintaining production discipline through March 2026, creating a sustained tight supply environment that supports higher oil prices and stronger energy company revenues.
These companies have direct exposure to crude oil prices - from upstream producers to service providers, each benefits immediately when oil prices strengthen due to supply constraints.
Professional analysts have identified this as a tactical opportunity where coordinated supply discipline creates a favourable environment for energy sector profitability and growth.
Eight OPEC+ nations have maintained their production pause through March 2026, creating a coordinated supply constraint that supports higher crude oil prices. This disciplined approach by major oil producers creates a tactical investment opportunity across the energy value chain, from upstream exploration to refining and services.
This collection focuses on companies directly impacted by tighter oil supply - including integrated oil majors, independent producers, refiners, and service providers. The group represents a cyclical opportunity that benefits from sustained higher energy prices and increased industry activity driven by profitable market conditions.
Each company was handpicked by professional analysts for its direct exposure to higher oil prices and market stability. From Exxon's upstream profits to Halliburton's drilling services, these firms are positioned to capitalise on the revenue opportunities created by OPEC+ supply discipline and sustained crude oil price strength.
Major OPEC+ nations are continuing their oil production pause, aiming to stabilize the market and support prices. This creates an investment opportunity in energy companies poised to benefit from higher oil prices and a renewed focus on energy efficiency.
This basket's total market capitalisation is $1.65T and is concentrated in a handful of large-cap energy stocks that anchor its profile.
XOM: $596.31B
CVX: $356.19B
COP: $128.80B
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+6
Here are a few of the assets in this group. Create an account to unlock the full list.
Use the growth calculator to see how much investing in these assets could return over one year, based on aggregated analyst sentiment provided by Refinitive Ltd.
Wenn Sie in diese Werte investieren:
In 12 Monaten könnte der Wert betragen:
+6.02%
Analysten erwarten im Durchschnitt, dass die Werte dieser Gruppe im nächsten Jahr um 6.02 % zulegen.
12 von 16 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.